For experimental cancer therapy, a struggle to ensure supply keeps up with demand – Science Magazine
Science Magazine |
For experimental cancer therapy, a struggle to ensure supply keeps up with demand
Science Magazine A transformative cancer therapy based on modified immune cells has lured doctors, companies, and patients alike, but many are hitting a frustrating roadblock: generating enough of these chimeric antigen receptor (CAR)-T cells to meet surging demand. |
